Cargando…

Synaptic and memory dysfunction induced by tau oligomers is rescued by up-regulation of the nitric oxide cascade

BACKGROUND: Soluble aggregates of oligomeric forms of tau protein (oTau) have been associated with impairment of synaptic plasticity and memory in Alzheimer’s disease. However, the molecular mechanisms underlying the synaptic and memory dysfunction induced by elevation of oTau are still unknown. MET...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acquarone, Erica, Argyrousi, Elentina K., van den Berg, Manon, Gulisano, Walter, Fà, Mauro, Staniszewski, Agnieszka, Calcagno, Elisa, Zuccarello, Elisa, D’Adamio, Luciano, Deng, Shi-Xian, Puzzo, Daniela, Arancio, Ottavio, Fiorito, Jole
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598340/ https://www.ncbi.nlm.nih.gov/pubmed/31248451 http://dx.doi.org/10.1186/s13024-019-0326-4

Ejemplares similares

LTP and memory impairment caused by extracellular Aβ and Tau oligomers is APP-dependent
por: Puzzo, Daniela, et al.
Publicado: (2017)

β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

An Intracellular Threonine of Amyloid-β Precursor Protein Mediates Synaptic Plasticity Deficits and Memory Loss
por: Lombino, Franco, et al.
Publicado: (2013)

Memory-enhancing effects of GEBR-32a, a new PDE4D inhibitor holding promise for the treatment of Alzheimer’s disease
por: Ricciarelli, Roberta, et al.
Publicado: (2017)

Caspase-9 mediates synaptic plasticity and memory deficits of Danish dementia knock-in mice: caspase-9 inhibition provides therapeutic protection
por: Tamayev, Robert, et al.
Publicado: (2012)

A role for tau in learning, memory and synaptic plasticity
por: Biundo, Fabrizio, et al.
Publicado: (2018)

Extracellular Tau Oligomers Produce An Immediate Impairment of LTP and Memory
por: Fá, M., et al.
Publicado: (2016)

PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease
por: Teich, Andrew F., et al.
Publicado: (2016)

Dynamin 1 Is Required for Memory Formation
por: Fà, Mauro, et al.
Publicado: (2014)

Heart failure-induced cognitive dysfunction is mediated by intracellular Ca(2+) leak through ryanodine receptor type 2
por: Dridi, Haikel, et al.
Publicado: (2023)

Role of phosphodiesterase 5 in synaptic plasticity and memory
por: Puzzo, Daniela, et al.
Publicado: (2008)

Transfixed by transgenics: how pathology assumptions are slowing progress in Alzheimer's disease and related dementia research
por: D'Adamio, Luciano
Publicado: (2023)

Aβ oligomers: role at the synapse
por: Puzzo, Daniela
Publicado: (2019)

Time-dependent reversal of synaptic plasticity induced by physiological concentrations of oligomeric Aβ42: an early index of Alzheimer’s disease
por: Koppensteiner, Peter, et al.
Publicado: (2016)

Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

BRI2-mediated regulation of TREM2 processing in microglia and its potential implications for Alzheimer’s disease and related dementias
por: Yin, Tao, et al.
Publicado: (2023)

Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers I: Abeta 42 Oligomer Binding to Specific Neuronal Receptors Is Displaced by Drug Candidates That Improve Cognitive Deficits
por: Izzo, Nicholas J., et al.
Publicado: (2014)

Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer’s Risk Variant
por: Tambini, Marc D., et al.
Publicado: (2020)

Knock-in rats with homozygous PSEN1(L435F) Alzheimer mutation are viable and show selective γ-secretase activity loss causing low Aβ40/42 and high Aβ43
por: Tambini, Marc D., et al.
Publicado: (2020)

Pro-cognitive effect of upregulating cyclic guanosine monophosphate signalling during memory acquisition or early consolidation is mediated by increased AMPA receptor trafficking
por: Argyrousi, Elentina K, et al.
Publicado: (2019)

Leucine Carboxyl Methyltransferase 1 Overexpression Protects Against Cognitive and Electrophysiological Impairments in Tg2576 APP Transgenic Mice
por: Gnanaprakash, Madhumathi, et al.
Publicado: (2021)

The interactome of the amyloid β precursor protein family members is shaped by phosphorylation of their intracellular domains
por: Tamayev, Robert, et al.
Publicado: (2009)

β - but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia
por: Tamayev, Robert, et al.
Publicado: (2012)

CD74 interacts with APP and suppresses the production of Aβ
por: Matsuda, Shuji, et al.
Publicado: (2009)

Initial assessment of the spatial learning, reversal, and sequencing task capabilities of knock-in rats with humanizing mutations in the Aβ-coding region of App
por: Pham, Hoa, et al.
Publicado: (2022)

Beyond amyloid: altered gene function in neurodegenerative diseases
por: Yesiltepe, Metin, et al.
Publicado: (2023)

A role for cGMP-dependent protein kinase II in AMPA receptor trafficking and synaptic plasticity
por: Serulle, Yafelle, et al.
Publicado: (2009)

Beta‐amyloid 1‐42 monomers, but not oligomers, produce PHF‐like conformation of Tau protein
por: Manassero, Giusi, et al.
Publicado: (2016)

Correction: Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F., et al.
Publicado: (2018)

Abolishing Tau cleavage by caspases at Aspartate(421) causes memory/synaptic plasticity deficits and pre-pathological Tau alterations
por: Biundo, F, et al.
Publicado: (2017)

Corrigendum: Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer’s disease
por: Lee, Linda, et al.
Publicado: (2015)

Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease
por: Lee, Linda, et al.
Publicado: (2014)

Significance of Blood and Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease: Sensitivity, Specificity and Potential for Clinical Use
por: d’Abramo, Cristina, et al.
Publicado: (2020)

Facilitation of glutamate, but not GABA, release in Familial Alzheimer's APP mutant Knock‐in rats with increased β‐cleavage of APP
por: Tambini, Marc D., et al.
Publicado: (2019)

Generation and Initial Characterization of FDD Knock In Mice
por: Giliberto, Luca, et al.
Publicado: (2009)

Opposite changes in APP processing and human Aβ levels in rats carrying either a protective or a pathogenic APP mutation
por: Tambini, Marc D, et al.
Publicado: (2020)

A Role for Neutral Sphingomyelinase-mediated Ceramide Production in T Cell Receptor–induced Apoptosis and Mitogen-activated Protein Kinase–mediated Signal Transduction
por: Tonnetti, Laura, et al.
Publicado: (1999)

APP Is Cleaved by Bace1 in Pre-Synaptic Vesicles and Establishes a Pre-Synaptic Interactome, via Its Intracellular Domain, with Molecular Complexes that Regulate Pre-Synaptic Vesicles Functions
por: Del Prete, Dolores, et al.
Publicado: (2014)

The Familial dementia gene ITM2b/BRI2 facilitates glutamate transmission via both presynaptic and postsynaptic mechanisms
por: Yao, Wen, et al.
Publicado: (2019)

Deletion of the γ-secretase subunits Aph1B/C impairs memory and worsens the deficits of knock-in mice modeling the Alzheimer-like familial Danish dementia
por: Biundo, Fabrizio, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lg877vep9g0i62suh2eer9kujn